LUND, Sweden — February 19, 2025 — Cellevate AB, a biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, announced today the U.S. launch of its lead ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8534 ...

AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...

The Cell-Based Assays Market is projected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, at a 9.8% CAGR, driven by demand for drug disc ...

U.S. cellular starting materials Market Size was valued at USD 0.68 Billion in 2024 and is expected to reach USD 4.45 Billion by 2034 growing at a CAGR of 20.4%.

The global stem cell therapy market is poised for remarkable growth, with revenues projected to escalate from USD 394.50 million in 2024 to USD 2,612.92 million by 2033, reflecting a compelling ...

Veeva Systems, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s ...

Shah and colleagues take advantage of the presence of maternal and somatic ribosomes in zebrafish and confirm their differential expression during development. The authors convincingly show that ...

Casper, chairman, president, and CEO of Thermo Fisher. Thermo Fisher has a portfolio of offerings in cell culture media and single-use technologies and Solventum’s filtration portfolio ...

Thermo Fisher’s acqusition of Solventum will strenghtnen its capabilities in bioprocessing. Image credit: JHVEPhoto / Shutterstock. Thermo Fisher Scientific is acquiring Solventum’s purification & ...